Hitchcock MJ - Search Results

1

Tenofovir exhibits low cytotoxicity in various human cell types: comparison with other nucleoside reverse transcriptase inhibitors.

Cihlar T, Birkus G, Greenwalt DE, Hitchcock MJ. Cihlar T, et al. Among authors: hitchcock mj. Antiviral Res. 2002 Apr;54(1):37-45. doi: 10.1016/s0166-3542(01)00210-8. Antiviral Res. 2002. PMID: 11888656

2

Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors.

Birkus G, Hitchcock MJ, Cihlar T. Birkus G, et al. Among authors: hitchcock mj. Antimicrob Agents Chemother. 2002 Mar;46(3):716-23. doi: 10.1128/AAC.46.3.716-723.2002. Antimicrob Agents Chemother. 2002. PMID: 11850253 Free PMC article.

3

Early nucleoside reverse transcriptase inhibitors for the treatment of HIV: a brief history of stavudine (D4T) and its comparison with other dideoxynucleosides.

Martin JC, Hitchcock MJ, De Clercq E, Prusoff WH. Martin JC, et al. Among authors: hitchcock mj. Antiviral Res. 2010 Jan;85(1):34-8. doi: 10.1016/j.antiviral.2009.10.006. Epub 2009 Oct 23. Antiviral Res. 2010. PMID: 19854224 Review.

4

Tenofovir alafenamide: A novel prodrug of tenofovir for the treatment of Human Immunodeficiency Virus.

Ray AS, Fordyce MW, Hitchcock MJ. Ray AS, et al. Among authors: hitchcock mj. Antiviral Res. 2016 Jan;125:63-70. doi: 10.1016/j.antiviral.2015.11.009. Epub 2015 Nov 27. Antiviral Res. 2016. PMID: 26640223 Free article. Review.

5

Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenine.

Starrett JE Jr, Tortolani DR, Hitchcock MJ, Martin JC, Mansuri MM. Starrett JE Jr, et al. Among authors: hitchcock mj. Antiviral Res. 1992 Sep;19(3):267-73. doi: 10.1016/0166-3542(92)90084-i. Antiviral Res. 1992. PMID: 1332606

6

Suppression of murine retroviral disease by 2',3'-didehydro-2',3'-dideoxythymidine (D4T).

Sidwell RW, Hitchcock M, Okleberry KM, Burger RA, Warren RP, Morrey JD. Sidwell RW, et al. Antiviral Res. 1992 Oct 1;19(4):313-24. doi: 10.1016/0166-3542(92)90012-t. Antiviral Res. 1992. PMID: 1334395

7

Effect of oral probenecid coadministration on the chronic toxicity and pharmacokinetics of intravenous cidofovir in cynomolgus monkeys.

Lacy SA, Hitchcock MJ, Lee WA, Tellier P, Cundy KC. Lacy SA, et al. Among authors: hitchcock mj. Toxicol Sci. 1998 Aug;44(2):97-106. doi: 10.1006/toxs.1998.2481. Toxicol Sci. 1998. PMID: 9742650

8

Susceptibility of human cytomegalovirus to cidofovir is unchanged after limited in vivo exposure to various regimens of drug.

Cherrington JM, Miner R, Hitchcock MJ, Lalezari JP, Drew WL. Cherrington JM, et al. Among authors: hitchcock mj. J Infect Dis. 1996 Apr;173(4):987-92. doi: 10.1093/infdis/173.4.987. J Infect Dis. 1996. PMID: 8603981 Clinical Trial.

9

Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patients.

Cundy KC, Petty BG, Flaherty J, Fisher PE, Polis MA, Wachsman M, Lietman PS, Lalezari JP, Hitchcock MJ, Jaffe HS. Cundy KC, et al. Among authors: hitchcock mj. Antimicrob Agents Chemother. 1995 Jun;39(6):1247-52. doi: 10.1128/AAC.39.6.1247. Antimicrob Agents Chemother. 1995. PMID: 7574510 Free PMC article.

10

Distribution and metabolism of intravitreal cidofovir and cyclic HPMPC in rabbits.

Cundy KC, Lynch G, Shaw JP, Hitchcock MJ, Lee WA. Cundy KC, et al. Among authors: hitchcock mj. Curr Eye Res. 1996 May;15(5):569-76. doi: 10.3109/02713689609000768. Curr Eye Res. 1996. PMID: 8670758

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters